Explore
Validate
Learn16154-1-AP
antibody from Proteintech Group
Targeting: CCR2
CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16154-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CCR2b-specific antibody
- Antibody type
- Polyclonal
- Description
- CCR2b-specific antibody (Cat. #16154-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Tissue-resident, extravascular Ly6c(-) monocytes are critical for inflammation in the synovium.
Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study.
Montgomery AB, Chen SY, Wang Y, Gadhvi G, Mayr MG, Cuda CM, Dominguez S, Moradeke Makinde HK, Gurra MG, Misharin AV, Mandelin AM, Ruderman EM, Thakrar A, Brar S, Carns M, Aren K, Akbarpour M, Filer A, Nayar S, Teososio A, Major T, Bharat A, Budinger GRS, Winter DR, Perlman H
Cell reports 2023 May 30;42(5):112513
Cell reports 2023 May 30;42(5):112513
Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study.
Zhai T, Mitamura T, Wang L, Kubota SI, Murakami M, Tanaka S, Watari H
Cancer medicine 2023 Apr;12(8):9697-9708
Cancer medicine 2023 Apr;12(8):9697-9708
No comments: Submit comment
No validations: Submit validation data